You need to create a user account to read this article.
With a subscription you unlock more content on BioStock.
Hemab Therapeutics raises USD 157 million in Series C
Text:
Kim Liedholm | [email protected]
Danish-American Hemab Therapeutics recently closed a Series C round of USD 157 million to further develop its pipeline in bleeding disorders. The round was led by Sofinnova Partner, accompanied by several renowned...